Luis H. Arroyo - Concepedia

Concepedia

Author

Luis H. Arroyo

Newark Beth Israel Medical Center

Also Known As

L. H. Arroyo, L. Hernandez Arroyo, L. Hernández Arroyo, L.H. Arroyo, Luis H Arroyo, Luis H. Arroyo

29

Publications

1.5K

Citations

14

H-Index

27

Concepts

All Affiliations

Newark Beth Israel Medical Center Mount Sinai Medical Center Brigham and Women's Hospital University of South Florida Cleveland Clinic

LH

About

Luis H. Arroyo is an author at Newark Beth Israel Medical Center specializing in medicine, cardiology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	244
2	Biochemistry	1	1	37
3	Cell Biology	1	1	72
4	Cellular Physiology	1	1	72
5	Immunology	1	1	23

Luis H. Arroyo

×

14

Publications

1.5K

Citations

14

H-Index

	Year	Citations
Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After Experimental Myocardial Infarction in Mice Luís Eduardo Paim Rohde, Anique Ducharme, Luis H. Arroyo, Circulation	1999	439
Circulating Cell Adhesion Molecules Are Correlated With Ultrasound-Based Assessment of Carotid Atherosclerosis Luís Eduardo Paim Rohde, Richard Lee, Jose Rivero, Arteriosclerosis Thrombosis and Vascular Biology	1998	259
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice Bradley K. McConnell, Karen A. Jones, Diane Fatkin, Journal of Clinical Investigation	1999	258
Plasma Concentrations of Interleukin-6 and Abdominal Aortic Diameter Among Subjects Without Aortic Dilatation Luís Eduardo Paim Rohde, Luis H. Arroyo, Nader Rifai, Arteriosclerosis Thrombosis and Vascular Biology	1999	109
A Prospective, Randomized Trial of Single-Drug Versus Dual-Drug Immunosuppression in Heart Transplantation David A. Baran, Mark Zucker, Luis H. Arroyo, Circulation Heart Failure	2011	80
Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice Bradley K. McConnell, Karen A. Jones, Diane Fatkin, Journal of Clinical Investigation Cardiac MuscleCardiomyopathyHeart FailureMolecular PhysiologyPhysiology	1999	72
2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor Masayuki Ueeda, Robert D. Thompson, Luis H. Arroyo, Journal of Medicinal Chemistry	1991	62
A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide Indu Sabnani, Mark Zucker, Elliot D. Rosenstein, Lara D. Veeken	2008	58
Is Toxoplasmosis Prophylaxis Necessary in Cardiac Transplantation? Long-term Follow-up at Two Transplant Centers David A. Baran, Mamata Alwarshetty, Saad Alvi, The Journal of Heart and Lung Transplantation TransplantationTransplant CentersToxoplasmosis Prophylaxis NecessaryTransplant SurgeryCardiac Transplantation	2006	41
2-Aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor Masayuki Ueeda, Robert D. Thompson, Luis H. Arroyo, Journal of Medicinal Chemistry Cardiovascular PharmacologyAltmetric Attention ScorePharmacotherapyPre-clinical PharmacologyMolecular Pharmacology	1991	37

Page 1